Artykuły w czasopismach na temat „Liver cells Effect of drugs on”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Liver cells Effect of drugs on”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
HATANO, MOTOHISA. "Studies on free liver cells of rats. Effect of various drugs." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 18, nr 1 (1987): 87–88. http://dx.doi.org/10.3999/jscpt.18.87.
Pełny tekst źródłaRashid, M. S., Faheem Hadi, Zoya Muzaffar, H. M. Asif, Naveed Akhtar, Memoona Zahra, Maqbool, L. Sumreen, T. Shamim i A. Malik. "Cytotoxic Effect of Kigelia Africana Plant Extracts on Liver Cancer Cells". Pakistan Journal of Medical and Health Sciences 16, nr 10 (30.10.2022): 68–71. http://dx.doi.org/10.53350/pjmhs22161068.
Pełny tekst źródłaTing, Liu, Liu Juan i Yang Jian Qiong. "Effective Components of Hepatoprotective Drugs". Applied Mechanics and Materials 633-634 (wrzesień 2014): 533–36. http://dx.doi.org/10.4028/www.scientific.net/amm.633-634.533.
Pełny tekst źródłaLi, Rui, Chengyong Dong, Keqiu Jiang, Rui Sun, Yang Zhou, Zeli Yin, Jiaxin Lv, Junlin Zhang, Qi Wang i Liming Wang. "Rab27B enhances drug resistance in hepatocellular carcinoma by promoting exosome-mediated drug efflux". Carcinogenesis 41, nr 11 (11.05.2020): 1583–91. http://dx.doi.org/10.1093/carcin/bgaa029.
Pełny tekst źródłaRenovaldi, Dede, i Abdul Khalik Adam. "Potential of Sweet Basil (Ocimum basilicum) as a Hepatoprotector Agent for Liver Injury Related to Drugs". Muhammadiyah Medical Journal 1, nr 2 (16.11.2020): 63. http://dx.doi.org/10.24853/mmj.1.2.63-68.
Pełny tekst źródłaRenovaldi, Dede, i Abdul Khalik Adam. "Potential of Sweet Basil (Ocimum basilicum) as a Hepatoprotector Agent for Liver Injury Related to Drugs". Muhammadiyah Medical Journal 1, nr 2 (16.11.2020): 21. http://dx.doi.org/10.24853/mmj.1.2.21-26.
Pełny tekst źródłaLiao, Wei, Yan Tang, Zhengcui Hu, Chunyan Wang, Yi Chen, Yi Zhang i Wenhan Fan. "Preparation of Galactosyl Nanoparticles and Their Targeting Efficiency to Hepatocellular Carcinoma". Journal of Nanoscience and Nanotechnology 21, nr 2 (1.02.2021): 987–94. http://dx.doi.org/10.1166/jnn.2021.18666.
Pełny tekst źródłaÖNAL, Müge Gülcihan. "A New Approach: Treatment with Sodium Vanadate and Cisplatin Combination for Human Hepatocellular Carcinoma". Proceedings 40, nr 1 (25.12.2019): 14. http://dx.doi.org/10.3390/proceedings2019040014.
Pełny tekst źródłaTian, Shiliu, Rui Su, Ke Wu, Xuhan Zhou, Jaydutt V. Vadgama i Yong Wu. "Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells". Journal of Personalized Medicine 12, nr 8 (16.08.2022): 1318. http://dx.doi.org/10.3390/jpm12081318.
Pełny tekst źródłaHatta, Fazleen Haslinda Mohd, Ruhil Nadirah Che Omar, Mohd Ikhwan Ismail, Rosmadi Mohd Yusoff i Mohd Shihabuddin Ahmad Noorden. "Determining the Population Doubling Time of HepG2 and Huh-7 Cells and the Toxic Effect of Dimethyl Sulfoxide (DMSO)". ASM Science Journal 17 (7.11.2022): 1–5. http://dx.doi.org/10.32802/asmscj.2022.1238.
Pełny tekst źródłaBian, Xufei, Lan Jiang, Jing Zhou, Xiaoshu Guan, Jingyu Wang, Peng Xiang, Junyi Pan i Xiangnan Hu. "Improving Dissolution and Cytotoxicity by Forming Multidrug Crystals". Molecules 25, nr 6 (16.03.2020): 1343. http://dx.doi.org/10.3390/molecules25061343.
Pełny tekst źródłaSukhanov, D. S., E. D. Bazhanova i D. L. Teplyi. "ROLE OF HEPATOPROTECTORS AND IMMUNOMODULATORS IN REGULATION OF HEPATOCYTE APOPTOSIS INDUCED BY ANTITUBERCULOSIS TREATMENT". Annals of the Russian academy of medical sciences 68, nr 8 (19.08.2013): 45–50. http://dx.doi.org/10.15690/vramn.v68i8.723.
Pełny tekst źródłaChen, Wenzhuo, Xuefeng Li, Chengfei Liu, Jia He, Miao Qi, Yue Sun, Bingbing Shi i in. "β-Cyclodextrin modified Pt(II) metallacycle-based supramolecular hyperbranched polymer assemblies for DOX delivery to liver cancer cells". Proceedings of the National Academy of Sciences 117, nr 49 (23.11.2020): 30942–48. http://dx.doi.org/10.1073/pnas.2007798117.
Pełny tekst źródłaJing, Bolin, Gong Cheng, Jianjun Li, Zhuo A. Wang i Yuguang Du. "Inhibition of Liver Tumor Cell Metastasis by Partially Acetylated Chitosan Oligosaccharide on A Tumor-Vessel Microsystem". Marine Drugs 17, nr 7 (13.07.2019): 415. http://dx.doi.org/10.3390/md17070415.
Pełny tekst źródłaMedina-Pizaño, Mariana Yazmin, Marina Nayeli Medina-Rosales, Sandra Luz Martínez-Hernández, Liseth Rubi Aldaba-Muruato, José Roberto Macías-Pérez, Esperanza Sánchez-Alemán, Javier Ventura-Juárez i Martin Humberto Muñoz-Ortega. "Protective Effect of Curcumin against Doxazosin- and Carvedilol-Induced Oxidative Stress in HepG2 Cells". Oxidative Medicine and Cellular Longevity 2022 (11.02.2022): 1–15. http://dx.doi.org/10.1155/2022/6085515.
Pełny tekst źródłaYuhas, Yael, Eva Berent i Shai Ashkenazi. "Effect of Rifampin on Production of Inflammatory Mediators in HepG2 Liver Epithelial Cells". Antimicrobial Agents and Chemotherapy 55, nr 12 (19.09.2011): 5541–46. http://dx.doi.org/10.1128/aac.05149-11.
Pełny tekst źródłaCoelho, DR, ACAX De-Oliveira, TEM Parente, BS Leal, LF das Chagas, TN Oliveira, TD Saint’Pierre i FJR Paumgartten. "In vivo and in vitro effects of pentavalent antimony on mouse liver cytochrome P450s". Human & Experimental Toxicology 36, nr 1 (11.07.2016): 33–41. http://dx.doi.org/10.1177/0960327116637110.
Pełny tekst źródłaHorita, Yasuhiro, i Norio Doi. "Comparative Study of the Effects of Antituberculosis Drugs and Antiretroviral Drugs on Cytochrome P450 3A4 and P-Glycoprotein". Antimicrobial Agents and Chemotherapy 58, nr 6 (24.03.2014): 3168–76. http://dx.doi.org/10.1128/aac.02278-13.
Pełny tekst źródłaNoguchi, T., H. Fukumoto, Y. Mishina i M. Obinata. "Differentiation of erythroid progenitor (CFU-E) cells from mouse fetal liver cells and murine erythroleukemia (TSA8) cells without proliferation". Molecular and Cellular Biology 8, nr 6 (czerwiec 1988): 2604–9. http://dx.doi.org/10.1128/mcb.8.6.2604-2609.1988.
Pełny tekst źródłaNoguchi, T., H. Fukumoto, Y. Mishina i M. Obinata. "Differentiation of erythroid progenitor (CFU-E) cells from mouse fetal liver cells and murine erythroleukemia (TSA8) cells without proliferation." Molecular and Cellular Biology 8, nr 6 (czerwiec 1988): 2604–9. http://dx.doi.org/10.1128/mcb.8.6.2604.
Pełny tekst źródłaMo, Jiantao, Xuanbo Da, Qiaoxin Li, Jingjing Huang, Le Lu i Hongwei Lu. "The Study of Exosomes-Encapsulated mPEG-PLGA Polymer Drug-Loaded Particles for Targeted Therapy of Liver Cancer". Journal of Oncology 2022 (17.09.2022): 1–10. http://dx.doi.org/10.1155/2022/4234116.
Pełny tekst źródłaWang, Meixi, Jianrui Li, Hu Li, Biao Dong, Jing Jiang, Nannan Liu, Jiali Tan i in. "Down-Regulating the High Level of 17-Beta-Hydroxysteroid Dehydrogenase 13 Plays a Therapeutic Role for Non-Alcoholic Fatty Liver Disease". International Journal of Molecular Sciences 23, nr 10 (16.05.2022): 5544. http://dx.doi.org/10.3390/ijms23105544.
Pełny tekst źródłaAnju, Thangammal, Radhakrishnan Preetha, Raja Shunmugam, Shivshankar R. Mane, Jesu Arockiaraj i Shivasekar Ganapathy. "Non-Clinical Investigation of Tuberculosis Drugs: Conjugated Norbornene- Based Nanocarriers Toxic Impacts on Zebrafish". Current Nanomedicine 11, nr 4 (grudzień 2021): 224–36. http://dx.doi.org/10.2174/2468187312666211221130125.
Pełny tekst źródłaWu, Yafeng, Run Ma, Cuizhen Long, Yuanhui Shu, Ping He, Yan Zhou, Yining Xiang i Yuping Wang. "The protective effect of cannabinoid type II receptor agonist AM1241 on ConA-induced liver injury in mice via mitogen-activated protein kinase signalling pathway". International Journal of Immunopathology and Pharmacology 35 (styczeń 2021): 205873842110352. http://dx.doi.org/10.1177/20587384211035251.
Pełny tekst źródłaRuoß, Marc, Silas Rebholz, Marina Weimer, Carl Grom-Baumgarten, Kiriaki Athanasopulu, Ralf Kemkemer, Hanno Käß, Sabrina Ehnert i Andreas K. Nussler. "Development of Scaffolds with Adjusted Stiffness for Mimicking Disease-Related Alterations of Liver Rigidity". Journal of Functional Biomaterials 11, nr 1 (14.03.2020): 17. http://dx.doi.org/10.3390/jfb11010017.
Pełny tekst źródłaIrshad, Faiza, Kanwal Saeed, Muhammad Adeel Qama, Jamshad Latif, Zia Ul Mustafa i Lubaba Mukhtar. "Histological alterations in Rabbit liver after treatment with dexamethasone". Pakistan Journal of Medical and Health Sciences 15, nr 9 (30.09.2021): 2373–75. http://dx.doi.org/10.53350/pjmhs211592373.
Pełny tekst źródłaKomala M, Sathesh Kumar S i Padmavathy J. "Novel Drug Formulation for the Treatment of Hepatic Cancer- A Review". International Journal of Research in Pharmaceutical Sciences 11, nr 3 (29.07.2020): 4395–401. http://dx.doi.org/10.26452/ijrps.v11i3.2658.
Pełny tekst źródłaSmok, A. M., A. M. Malkova, D. A. Kudlay i A. A. Starshinova. "Possibilities for correcting hepatotoxic reactions during therapy in patients with COVID-19 (case report)". Translational Medicine 7, nr 6 (18.12.2020): 65–72. http://dx.doi.org/10.18705/2311-4495-2020-7-6-65-72.
Pełny tekst źródłaAkın, Bakır, Ökçesiz i Eken. "Evaluation of Cytotoxic Effects of Carnosic Acid Alone and Combination with Cisplatin in HepG2 Cells". Proceedings 40, nr 1 (31.12.2019): 39. http://dx.doi.org/10.3390/proceedings2019040039.
Pełny tekst źródłaSu, Qiang, Wei Kuang, Weiyi Hao, Jing Liang, Liang Wu, Chunmei Tang, Yali Wang i Tao Liu. "Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes". Mediators of Inflammation 2021 (19.02.2021): 1–13. http://dx.doi.org/10.1155/2021/8086253.
Pełny tekst źródłaAbolhasani, Ahmad, Fatemeh Heidari, Somayeh Noori, Shokoufeh Mousavi i Hoda Abolhasani. "Cytotoxicity Evaluation of Dimethoxy and Trimethoxy Indanonic Spiroisoxazolines Against Cancerous Liver Cells". Current Chemical Biology 14, nr 1 (26.05.2020): 38–47. http://dx.doi.org/10.2174/2212796813666190926112807.
Pełny tekst źródłaÖZGERMEN, Başak, Orhan YAVUZ i Ali Evren HAYDARDEDEOĞLU. "Investigation of the effects of mesenchymal stem cell administration on liver recovery in experimental hepatotoxicity model". Journal of Advances in VetBio Science and Techniques 7, nr 2 (31.08.2022): 185–93. http://dx.doi.org/10.31797/vetbio.1029373.
Pełny tekst źródłaAli Labib, Heba M. "Modification of alprazolam-induced liver injury by bone marrow-derived mesenchymal stem cells and the role of miRNA-192". European Journal of Anatomy 26, nr 6 (listopad 2022): 615–33. http://dx.doi.org/10.52083/ivll6465.
Pełny tekst źródłaZarrinpar, Ali. "Metabolic Pathway Inhibition in Liver Cancer". SLAS TECHNOLOGY: Translating Life Sciences Innovation 22, nr 3 (17.03.2017): 237–44. http://dx.doi.org/10.1177/2472630317698683.
Pełny tekst źródłaTeixeira, Sarah Fernandes, Isabella dos Santos Guimarães, Klesia Pirola Madeira, Renata Dalmaschio Daltoé, Ian Victor Silva i Leticia Batista Azevedo Rangel. "Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells". Jornal Brasileiro de Pneumologia 39, nr 6 (grudzień 2013): 644–49. http://dx.doi.org/10.1590/s1806-37132013000600002.
Pełny tekst źródłaDomnina, L. V., J. A. Rovensky, J. M. Vasiliev i I. M. Gelfand. "Effect of microtubule-destroying drugs on the spreading and shape of cultured epithelial cells". Journal of Cell Science 74, nr 1 (1.03.1985): 267–82. http://dx.doi.org/10.1242/jcs.74.1.267.
Pełny tekst źródłaChen, Zhiliang, Tony C. H. Chow, Shicong Wang, Gigi C. T. Leung, Sharon L. Y. Wu i David T. Yew. "Reaction of the Liver upon Long-Term Treatment of Fluoxetine and Atorvastatin Compared with Alcohol in a Mouse Model". Journal of Toxicology 2021 (30.12.2021): 1–8. http://dx.doi.org/10.1155/2021/9974969.
Pełny tekst źródłaLin, Chun-Ching, Jer-Min Lin i Hui-Fen Chiu. "Studies on Folk Medicine "Thang-kau-tin" from Taiwan (I) The Anti-inflammatory and Liver-protective Effect". American Journal of Chinese Medicine 20, nr 01 (styczeń 1992): 37–50. http://dx.doi.org/10.1142/s0192415x92000059.
Pełny tekst źródłaZheng, Rendong, Kemian Liu, Kun Chen, Wen Cao, Lin Cao, Huifeng Zhang, Hongping Sun i Chao Liu. "Lithium Carbonate in the Treatment of Graves’ Disease with ATD-Induced Hepatic Injury or Leukopenia". International Journal of Endocrinology 2015 (2015): 1–7. http://dx.doi.org/10.1155/2015/694023.
Pełny tekst źródłaBaothman, Othman, Bhaa Nagaty, Mazin Zamzami i Hasan Al-Talhi. "In vivo protective effect of cinnamon aqueous extract in carbon tetrachloride-treated male albino rats". Acta Scientiarum. Health Sciences 43 (13.10.2021): e52826. http://dx.doi.org/10.4025/actascihealthsci.v43i1.52826.
Pełny tekst źródłaMishra, Nidhi, Narayan Prasad Yadav, Vineet Kumar Rai, Priyam Sinha, Kuldeep Singh Yadav, Sanyog Jain i Sumit Arora. "Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance". BioMed Research International 2013 (2013): 1–20. http://dx.doi.org/10.1155/2013/382184.
Pełny tekst źródłaAbdu, Suzan, Nouf Juaid, Amr Amin, Mohamed Moulay i Nabil Miled. "Therapeutic Effects of Crocin Alone or in Combination with Sorafenib against Hepatocellular Carcinoma: In Vivo & In Vitro Insights". Antioxidants 11, nr 9 (25.08.2022): 1645. http://dx.doi.org/10.3390/antiox11091645.
Pełny tekst źródłaPoojari, Radhika, Rohit Srivastava i Dulal Panda. "Microtubule targeted therapeutics loaded polymeric assembled nanospheres for potentiation of antineoplastic activity". Faraday Discussions 186 (2016): 45–59. http://dx.doi.org/10.1039/c5fd00123d.
Pełny tekst źródłaWeiz, Gisela, Alina L. Gonzalez, Flavia Piccioni, Mariel Fusco, Marco Diaz Gutiérrez, Guillermo Mazzolini, Javier D. Breccia, Mariana Malvicini i Maria I. Molejon. "Abstract 5447: Enhanced antitumoral effect of the glycosylated 4-methylumbelliferone in hepatocellular carcinoma". Cancer Research 82, nr 12_Supplement (15.06.2022): 5447. http://dx.doi.org/10.1158/1538-7445.am2022-5447.
Pełny tekst źródłaPantea, Valeriana, Vitalie Cobzac, Olga Tagadiuc, Victor Palarie i Valentin Gudumac. "In Vitro Evaluation of the Cytotoxic Potential of Thiosemicarbazide Coordinating Compounds in Hepatocyte Cell Culture". Biomedicines 11, nr 2 (26.01.2023): 366. http://dx.doi.org/10.3390/biomedicines11020366.
Pełny tekst źródłaDobrzynska, Malgorzata, Marta Napierala i Ewa Florek. "Flavonoid Nanoparticles: A Promising Approach for Cancer Therapy". Biomolecules 10, nr 9 (2.09.2020): 1268. http://dx.doi.org/10.3390/biom10091268.
Pełny tekst źródłaBalabolkin, M. I., i L. B. Nedosugova. "The use of second generation sulfonylurea agents and the role of glurenorm in the therapy of non-insulin-dependent diabetes mellitus". Problems of Endocrinology 41, nr 2 (15.04.1995): 11–14. http://dx.doi.org/10.14341/probl11362.
Pełny tekst źródłaLi, Shao-wei, Yue Cai, Xin-li Mao, Sai-qin He, Ya-hong Chen, Ling-ling Yan, Jing-jing Zhou, Ya-qi Song, Li-ping Ye i Xian-bin Zhou. "The Immunomodulatory Properties of Mesenchymal Stem Cells Play a Critical Role in Inducing Immune Tolerance after Liver Transplantation". Stem Cells International 2021 (4.09.2021): 1–14. http://dx.doi.org/10.1155/2021/6930263.
Pełny tekst źródłaLin, Chun-Ching, Pei-Chen Huang i Jer-Min Lin. "Antioxidant and Hepatoprotective Effects ofAnoectochilus formosanusandGynostemma pentaphyllum". American Journal of Chinese Medicine 28, nr 01 (styczeń 2000): 87–96. http://dx.doi.org/10.1142/s0192415x00000118.
Pełny tekst źródłaMcVicker, Benita L., Frederick G. Hamel, Ronda L. Simpson i Robert G. Bennett. "A Selective PPARγ Modulator Reduces Hepatic Fibrosis". Biology 9, nr 7 (2.07.2020): 151. http://dx.doi.org/10.3390/biology9070151.
Pełny tekst źródła